Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DATOPOTAMAB DERUXTECAN-DLNK: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

89.2%
Female
10.8%
Male

Age Information

The average age of patients reporting adverse events with DATOPOTAMAB DERUXTECAN-DLNK is 61.4 years.

Geographic Distribution

The majority of adverse event reports for DATOPOTAMAB DERUXTECAN-DLNK originate from US.

Report Summary & Outcomes

165
Total Reports
165
As Primary/Secondary Suspect
36
Deaths Reported
33
Hospitalizations
3
Disabilities

Reporting Timeline

First adverse event report: 20250101. Most recent report: 20250919. View full timeline →

More About DATOPOTAMAB DERUXTECAN-DLNK

DATOPOTAMAB DERUXTECAN-DLNK Full Profile Reports by Year Drug Interactions